학술논문

Soluble human epidermal growth factor receptor 2 (HER2) levels in patients with HER2-positive breast cancer receiving chemotherapy with or without trastuzumab: Results from North Central Cancer Treatment Group adjuvant trial N9831
Document Type
Article
Source
In: Cancer. (Cancer, 1 August 2013, 119(15):2675-2682)
Subject
Language
English
ISSN
0008543X
10970142